United States: Federal Circuit Patent Updates - January 2016

Last Updated: February 4 2016
Article by WilmerHale

View previous updates...

Purdue Pharma L.P. v. Epic Pharma, LLC (No. 2014-1294, 2/3/16) (Prost, Reyna, Stark)

February 1, 2016 9:22 AM

Prost, J. Affirming finding that formulation patents were obvious and anticipated in Hatch-Waxman case. With respect to one patent, the district court correctly disregarded process limitations in a product by process claim when evaluating obviousness. With respect to a second patent, testing showed a claim limitation was inherent in the prior art reference, and the district court did not improperly combine discrete disclosures of the prior art reference.

A full version of the text is available in PDF form.

Akzo Nobel Coatings, Inc. v. Dow Chemical Company (No. 2015-1331, 2015-1389, 1/29/16) (Lourie, Reyna, Chen)

January 29, 2016 6:43 PM

Lourie, J. Affirming summary judgment of non-infringement and that the claims are not indefinite. An expert's conclusory declaration did not create an issue of fact on the doctrine of equivalents. In affirming the summary judgment regarding definiteness, the Court found the district court's evaluation of the extrinsic evidence not "clearly erroneous."

A full version of the text is available in PDF form.

Avid Technology, Inc. v. Harmonic, Inc. (No. 2015-1246, 1/29/16) (Reyna, Taranto, Stoll)

January 29, 2016 4:54 PM

Taranto, J. Where there was a general verdict of infringement, a remand for a new trial was required based on an unduly narrow claim construction of one element, but the evidence did not compel a finding of infringement of another element, that had not been construed by the district court. The claim construction error was the result of an incorrect finding of a disclaimer in the file history.

A full version of the text is available in PDF form.

Agilent Technologies v. Waters Technologies (No. 2015-1280, 1/29/16) (Moore, O'Malley, Taranto)

January 29, 2016 2:06 PM

O'Malley, J. Dismissing appeal of an inter partes reexamination because appellant was not the same as the third-party requester and did not demonstrate that it was the requester's successor-in-interest.

A full version of the text is available in PDF form.

Lumen View Technology LLC v. Findthebest.com, Inc. (No. 2015-1275, 2015-1325, 1/22/16) (Lourie, Moore, Wallach)

January 22, 2016 1:44 PM

Lourie, J. Affirming finding that case was exceptional based on a frivolous infringement theory but remanding based on the failure of  the district court to justify award of a multiplier on the defendant's fees.

A full version of the text is available in PDF form.

Pfizer Inc. v. Lee (No. 2015-1265, 1/22/16) (Newman, Dyke, O'Malley)

January 22, 2015 10:28 AM

O'Malley, J. Affirming district court's decision that Patent Office had properly calculated a patent term adjustment. The examiner's initial rejection, which included an incorrect restriction requirement that was replaced by a later corrected office action, was sufficiently clear to stop the delay period from accruing after it issued. Newman, J., dissented.

A full version of the text is available in PDF form.

Mortgage Grader, Inc. v. First Choice Loan Services (No. 2015-1415, 1/20/16) (O'Malley, Taranto, Stark)

January 20, 2016 3:35 PM

Stark, J. Affirming summary judgment that claims directed to methods for evaluating loan packages were directed to ineligible subject matter. In addition, the district court did not abuse its discretion in refusing to strike defendant's invalidity contentions, which were justified in adding a 101 defense after Alice Corp. v. CLS Bank was decided by the Supreme Court.

A full version of the text is available in PDF form.

Biomet Orthopedics, LLC v. Puget Bioventures, LLC (No. 2015-1468, 1/14/16) (Moore, O'Malley, Taranto)

January 14, 2016 1:15 PM

Moore, J. Vacating Board decision for some claims, and affirming Board decision for other claims, in inter partes reexamination. The patent expired after the Board decision but before the Court's decision. "This case presents an unusual procedural issue... Amendments are not effective until the certificate issues... Thus, the [amended claims] cannot issue. We therefore vacate the Board's decision with respect to the [amended claims] and remand for the PTO to take whatever action it deems appropriate."

A full version of the text is available in PDF form.

Ethicon Endo-Surgery, Inc. v. Covidien LP (No. 2014-1771, 1/13/16) (Newman, Dyk, Taranto)

January 13, 2016 10:28 AM

Dyk, J. Affirming Board decision in IPR finding claims related to a surgical device obvious. "[W]e hold that neither the statute nor the Constitution precludes the same panel of the Board that made the decision to institute inter partes review from making the final determination." The Court also held that "35 U.S.C. § 314(d) does not preclude us from hearing [patent owner's] challenge to the authority of the Board to render a final decision." Newman, J. dissented..

A full version of the text is available in PDF form.

In re Urbanski (No. 2015-1272, 1/8/16) (Lourie, Bryson, Chen)

January 8, 2016 12:52 PM

Lourie, J. Affirming Board's decision that claims related to enzymatic hydrolysis of soy fiber are obvious over the combination of two references, Gross and Wong. "As the Board properly found, one of ordinary skill would have been motivated to pursue the desirable properties taught by Wong, even if that meant forgoing the benefit taught by Gross. And [the] claims do not require Gross's benefit that is arguably lost by combination with Wong. The Board therefore did not err in rejecting [applicant's] inoperability argument."

A full version of the text is available in PDF form.

Wi-Lan, Inc. v. Apple Inc. (No. 2014-1437, 2014-1485, 1/8/16) (Reyna, Wallach, Hughes)

January 8, 2016 4:41 PM

Reyna, J. Affirming district court's denial of JMOL as to non-infringement because the jury's verdict of non-infringement was supported by substantial evidence. Also, reversing district court's JMOL determination of no invalidity because that determination was based on a "post-verdict reconstruction of the claims." Regarding non-infringement, use of the term "the" in the claims imposed an order, requiring data symbols to be randomized before being combined. Because the accused products do not use the claimed order, they do not infringe literally or by equivalents. It was reasonable for the jury to conclude that the differences between the claim and the accused product were substantial based on expert testimony that the accused products, which contain millions of transistors, eliminate in the relevant portion of the chip "20 out of a few hundred transistors."

A full version of the text is available in PDF form.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions